A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1
- Author
- ROSE, P. G1 ; BRUNETTO, V. L2 ; VANLE, L3 ; BELL, J4 ; WALKER, J. L5 ; LEE, R. B6
[1] Case Western Reserve University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals of Cleveland, Cleveland, Ohio 44106, United States
[2] Gynecologic Oncology Group, Roswell Park Cancer Institute, Buffalo, New York 14263, United States
[3] Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27597, United States
[4] Ohio State University, Division of Gynecologic Oncology, Riverside Methodist Hospital, Columbus, Ohio 43214, United States
[5] Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma 73190, United States
[6] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington 98195, United States - Source
Gynecologic oncology (Print). 2000, Vol 78, Num 2, pp 212-216 ; ref : 29 ref
- CODEN
- GYNOA3
- ISSN
- 0090-8258
- Scientific domain
- Medical oncology; Obstetrics, gynecology, andrology
- Publisher
- Elsevier, San Diego, CA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adulte Anastrozole Anticancéreux Carcinome Chimiothérapie Efficacité traitement Endomètre Essai clinique phase II Femelle Personne âgée Traitement Appareil génital femelle pathologie Homme Tumeur maligne Utérus pathologie
- Keyword (en)
- Adult Anastrozole Antineoplastic agent Carcinoma Chemotherapy Treatment efficiency Endometrium Phase II trial Female Elderly Treatment Female genital diseases Human Malignant tumor Uterine diseases
- Keyword (es)
- Adulto Anastrozol Anticanceroso Carcinoma Quimioterapia Eficacia tratamiento Endometrio Ensayo clínico fase II Hembra Anciano Tratamiento Aparato genital hembra patología Hombre Tumor maligno Utero patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A06 Clinical trial. Drug monitoring
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1473729
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1006/gyno.2000.5865 
https://dx.doi.org/10.1006/gyno.2000.5865
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Gynecologic oncology (Print)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Gynecol. oncol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"212\";s:8:\"\u0000*\u0000epage\";s:3:\"216\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0090-8258\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ROSE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"BRUNETTO, V. L\";i:1;s:8:\"VANLE, L\";i:2;s:7:\"BELL, J\";i:3;s:12:\"WALKER, J. L\";i:4;s:9:\"LEE, R. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GYNOA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Gynecologic oncology (Print)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Gynecol. oncol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"212\";s:8:\"\u0000*\u0000epage\";s:3:\"216\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0090-8258\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ROSE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"BRUNETTO, V. L\";i:1;s:8:\"VANLE, L\";i:2;s:7:\"BELL, J\";i:3;s:12:\"WALKER, J. L\";i:4;s:9:\"LEE, R. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GYNOA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Gynecologic oncology (Print)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Gynecol. oncol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"212\";s:8:\"\u0000*\u0000epage\";s:3:\"216\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0090-8258\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ROSE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"BRUNETTO, V. L\";i:1;s:8:\"VANLE, L\";i:2;s:7:\"BELL, J\";i:3;s:12:\"WALKER, J. L\";i:4;s:9:\"LEE, R. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GYNOA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Gynecologic oncology (Print)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Gynecol. oncol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"212\";s:8:\"\u0000*\u0000epage\";s:3:\"216\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0090-8258\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ROSE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"BRUNETTO, V. L\";i:1;s:8:\"VANLE, L\";i:2;s:7:\"BELL, J\";i:3;s:12:\"WALKER, J. L\";i:4;s:9:\"LEE, R. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GYNOA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1006\/gyno.2000.5865\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Gynecologic oncology (Print)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Gynecol. oncol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"212\";s:8:\"\u0000*\u0000epage\";s:3:\"216\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0090-8258\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ROSE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:14:\"BRUNETTO, V. L\";i:1;s:8:\"VANLE, L\";i:2;s:7:\"BELL, J\";i:3;s:12:\"WALKER, J. L\";i:4;s:9:\"LEE, R. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GYNOA3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A gynecologic oncology group study1\";s:8:\"\u0000*\u0000place\";s:13:\"San Diego, CA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
